Salvatore Siena Selected Research

Salvatore Siena Research Topics

Disease

118	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 07/2004
105	Neoplasms (Cancer) 10/2022 - 05/2002
21	Disease Progression 01/2021 - 05/2002
19	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2005
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 05/2009
6	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2003
5	Circulating Neoplastic Cells 05/2021 - 02/2014
5	Fatigue 01/2020 - 08/2002
5	Exanthema (Rash) 06/2016 - 05/2005
4	Sarcoma (Soft Tissue Sarcoma) 10/2020 - 03/2007
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 05/2002
4	Anemia 03/2009 - 08/2002
3	Stomach Neoplasms (Stomach Cancer) 01/2021 - 11/2019
3	Adenocarcinoma 01/2021 - 02/2014
3	Melanoma (Melanoma, Malignant) 01/2021 - 01/2017
3	Colonic Neoplasms (Colon Cancer) 01/2019 - 05/2008
3	Lung Neoplasms (Lung Cancer) 01/2018 - 08/2002
3	Pancreatic Neoplasms (Pancreatic Cancer) 02/2015 - 01/2008
3	Iron Deficiencies 03/2009 - 01/2008
3	Neutropenia 12/2006 - 05/2003
2	Carcinogenesis 06/2020 - 03/2014
2	Rectal Neoplasms (Rectal Cancer) 01/2020 - 09/2019
2	Ovarian Neoplasms (Ovarian Cancer) 12/2016 - 01/2012
2	Pain (Aches) 04/2016 - 12/2012
2	Alopecia (Baldness) 07/2014 - 12/2012
2	Chronic Renal Insufficiency 03/2009 - 01/2008
2	Medulloblastoma 11/2008 - 06/2005
2	Febrile Neutropenia 10/2003 - 05/2003

Drug/Important Bio-Agent (IBA)

38	ErbB Receptors (EGF Receptor)IBA 01/2022 - 06/2003
37	Panitumumab (Vectibix)FDA Link 01/2020 - 05/2005
32	Cetuximab (Erbitux)FDA Link 01/2021 - 07/2004
27	Monoclonal AntibodiesIBA 01/2022 - 05/2005
16	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2009
11	entrectinibIBA 10/2022 - 12/2015
11	Pharmaceutical PreparationsIBA 01/2021 - 08/2009
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2022 - 11/2010
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2011
9	Phosphotransferases (Kinase)IBA 01/2022 - 06/2013
8	Circulating Tumor DNAIBA 05/2021 - 02/2014
8	regorafenibIBA 06/2020 - 01/2013
7	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 04/2008
7	Trastuzumab (Herceptin)FDA Link 01/2021 - 11/2015
7	Gemcitabine FDA Link 02/2016 - 07/2007
6	AntibodiesIBA 01/2022 - 08/2010
6	Cisplatin (Platino)FDA LinkGeneric 02/2021 - 07/2007
6	Lapatinib (GW572016)FDA Link 01/2021 - 11/2015
6	Cell-Free Nucleic AcidsIBA 01/2021 - 08/2015
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2020 - 06/2012
5	Calcibiotic Root Canal SealerIBA 12/2016 - 02/2014
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
4	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2020
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2020
4	Biological ProductsIBA 01/2020 - 12/2010
4	Irinotecan (Camptosar)FDA LinkGeneric 12/2016 - 07/2004
4	IronIBA 03/2009 - 11/2004
3	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 12/2010
3	trastuzumab deruxtecanIBA 01/2021 - 01/2020
3	pertuzumabIBA 01/2021 - 01/2020
3	Anaplastic Lymphoma KinaseIBA 11/2020 - 10/2014
3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 11/2010
3	Codon (Codons)IBA 06/2016 - 10/2010
3	Sorafenib (BAY 43-9006)FDA Link 07/2014 - 08/2009
3	Growth Factor ReceptorsIBA 03/2014 - 05/2005
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2012 - 05/2009
3	Hemoglobins (Hemoglobin)IBA 04/2008 - 08/2002
3	Filgrastim (Neupogen)FDA Link 12/2006 - 05/2003
3	pegfilgrastim (Neulasta)FDA Link 12/2006 - 05/2003
3	AntigensIBA 12/2005 - 05/2004
2	pembrolizumabIBA 10/2022 - 01/2022
2	VaccinesIBA 01/2022 - 10/2005
2	TropomyosinIBA 01/2022 - 01/2016
2	tyrosine receptor (receptor, tyrosine)IBA 10/2021 - 01/2016
2	encorafenibIBA 01/2021 - 10/2020
2	human ERBB2 proteinIBA 01/2021 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 06/2020 - 03/2014
2	dabrafenibIBA 01/2020 - 01/2018
2	trametinibIBA 01/2020 - 01/2018
2	Dacarbazine (DIC)FDA LinkGeneric 01/2017 - 04/2013
2	Lenalidomide (CC 5013)FDA Link 01/2013 - 01/2013
2	Zoledronic Acid (Zometa)FDA Link 12/2012 - 11/2012
2	Denosumab FDA Link 12/2012 - 11/2012
2	HematinicsIBA 04/2008 - 01/2008
2	Neoplasm Antigens (Tumor Antigens)IBA 10/2005 - 05/2004
2	CytokinesIBA 10/2005 - 10/2003
2	Darbepoetin alfa (Aranesp)FDA Link 10/2003 - 08/2002
1	dostarlimabIBA 10/2022
1	larotrectinibIBA 10/2022
1	disitamab vedotinIBA 03/2022
1	trastuzumab duocarmazineIBA 03/2022

Therapy/Procedure

75	Therapeutics 10/2022 - 08/2002
38	Drug Therapy (Chemotherapy) 01/2022 - 08/2002
7	Immunotherapy 01/2022 - 11/2005
4	Stem Cell Transplantation 10/2020 - 05/2002
3	Retreatment 02/2022 - 02/2019
3	Radiotherapy 02/2021 - 11/2008
3	Precision Medicine 01/2021 - 11/2011
3	Transplantation 10/2020 - 05/2002
3	Injections 12/2006 - 05/2003
2	Aftercare (After-Treatment) 04/2016 - 05/2005